Clinical Trials Logo

Smoking Cessation clinical trials

View clinical trials related to Smoking Cessation.

Filter by:

NCT ID: NCT04897568 Completed - Lung Cancer Clinical Trials

Shared Decision Making in Rural Primary Care Lung Cancer Screening and Smoking Cessation

SDM-LCS-SC
Start date: July 15, 2020
Phase: N/A
Study type: Interventional

The intervention is aimed to improve adherence to the lung cancer screening (LCS) guidelines and Centers for Medicare and Medicaid Services (CMS) coverage criteria to conduct shared decision-making (SDM) and provide smoking cessation services in rural primary care practices.

NCT ID: NCT04896554 Completed - Smoking Cessation Clinical Trials

Comparison of the Health Literacy of Our Patients Who Quit Smoking and Who Cannot Quit Smoking

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

The aim of the study was determined to examine the relationship between the health literacy scales of the patients who came to the smoking cessation clinic and their smoking cessation success. The patient follow-up files registered in the archive of the smoking cessation clinic will be scanned for the last 2 years and the demographic data and follow-up information of the patients will be reached. Patients who have completed the 1-year follow-up period will be contacted by phone, questioning whether they smoke or not, and will be invited to answer the health literacy scale. Accepting patients will be divided into two groups as those who quit smoking and those who cannot, and health literacy scales will be compared.

NCT ID: NCT04893460 Completed - Smoking Cessation Clinical Trials

CoQuit Study for Smoking Cessation

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This study investigates the feasibility of a cognitive dissonance-based mobile app for smoking cessation (CDI). Cognitive dissonance refers to the conflict between beliefs and behaviors; interventions are designed to promote this conflict to motivate people to change their behavior. Recent research has demonstrated the efficacy and potential of using cognitive dissonance interventions for a wide range of health and behavioral problems including smoking cessation. This study will develop an initial version of the CDI mobile app and evaluate the app in an evaluation study with 60 adult smokers.

NCT ID: NCT04890223 Completed - Smoking Cessation Clinical Trials

Efficacy of Brief MI Delivered Via Mobile Instant Messaging to Help Unmotivated Smokers With Chronic Diseases to Quit

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This study aims to examine the efficacy of brief MI delivered by mobile instant messaging tools in promoting smoking cessation among unmotivated smokers with chronic diseases. Participants in the intervention group will receive a brief MI intervention while the control group will receive a placebo intervention.

NCT ID: NCT04868474 Completed - Smoking Cessation Clinical Trials

Combining Default Choices and a Decision Aid to Improve Tobacco Cessation

FIRST
Start date: June 15, 2021
Phase: N/A
Study type: Interventional

The FIRST cluster randomized trial will evaluate the effect of 1) a training program encouraging general practitioners to offer smoking cessation treatment as a default choice to all current smokers consulting a general practitioner (GP), and 2) an interactive, electronic decision aid to guide smoking cessation treatment, on the proportion of current smokers seen in primary care who have quit smoking 6 months after a baseline visit to their GP, as compared to enhanced usual care.

NCT ID: NCT04864327 Completed - Smoking Cessation Clinical Trials

Smoking Intervention Among Patients With Diabetes

Start date: May 5, 2011
Phase: N/A
Study type: Interventional

This study determined the prevalence of tobacco smoking among patients with diabetes and evaluated the impact of a diabetes-specific tobacco cessation intervention on tobacco cessation outcomes and on the glycaemic control, blood pressure, lipid profile, complications, comorbidities and number of cigarettes consumed per day among the patients.

NCT ID: NCT04857515 Completed - Smoking Cessation Clinical Trials

Clinical Learning Study for a Mobile Smoking Cessation Program

Start date: March 12, 2021
Phase:
Study type: Observational

The purpose of this study are to obtain learnings regarding the Digital Therapeutic (DTx) experience of Clickotine, including acceptability and preference of the overall program and specific DTx components, as well as to obtain learnings related to adult participants' use of the DTx for smoking cessation.

NCT ID: NCT04857047 Completed - Smoking Cessation Clinical Trials

A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

Start date: March 31, 2021
Phase: Phase 1
Study type: Interventional

This is a randomized, multiple doses, crossover clinical study to compare the pharmacokinetic characteristics and the safety between administration of BR9003 and BR9003A in healthy adult subjects. Within each period, randomized subjects will be taken 2 dosing regimens of administrating BR9003 once a day for six days or BR9003A twice a day for six days.

NCT ID: NCT04854616 Completed - Smoking Cessation Clinical Trials

Cessation of Smoking Trial in the Emergency Department

CoSTED
Start date: January 4, 2022
Phase: N/A
Study type: Interventional

The Cessation of Smoking Trial in the Emergency Department (CoSTED) is an National Institute for Health Research (NIHR) Health Technology Assessment (HTA) funded randomised controlled trial (RCT). The research question is "in people attending the Emergency Department who smoke, does a brief intervention (including the provision of an electronic cigarette (e-cigarette) and referral to stop smoking services) increase smoking cessation in comparison with usual care and is it cost effective?" The trial includes an internal pilot, health economic evaluation and process evaluation. The primary outcome is smoking cessation, self-reported as continuous smoking abstinence, biochemically validated by carbon monoxide monitoring with cut off of ≥8ppm. The sample size is 972 (486 in intervention and control) across 6 sites.

NCT ID: NCT04846998 Completed - Smoking Cessation Clinical Trials

A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

Start date: March 25, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetics and safety of oral administration of BR9003 compared with BR9003A in healthy adult subjects